THCTTHC Therapeutics, Inc.

About THC Therapeutics, Inc. (THCT)

THC Therapeutics, Inc. (THCT) is a Drug Manufacturers - Specialty & Generic company headquartered in Jacksboro, TX, United States whose shares trade over-the-counter on the Expert Market tier.

THC Therapeutics, Inc. (THCT), a reporting company with the SEC, is actively focused on developing into a consolidation catalyst in the cannabis industry and modern healthcare space via mergers and acquisitions. The company is presently developing their intellectual property in both ancillary technologies and formulations. One of the company's active projects is the development of their patented dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to greatly accelerate the drying time of cannabis while sanitizing it. The dHydronator can be used to dry a variety of herbs; it has been specifically tested for use with cannabis, and it can reduce the drying time for cannabis from 10-14 days to less than 14 hours. THC Therapeutics is seeking partnerships in the Cannabis, Psychedelics & Health/Wellness industries in the United States & Canada.

Products and services

Development of seed to sale products, services, proprietary technologies and formulations in the cannabis industry.

THCT key facts

Ticker symbol

THCT

Market tier

Expert Market

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Jacksboro, TX, United States

Country of incorporation

US

Year of incorporation

2007

Employees

1

Estimated market cap

$16.1K (as of Apr 11, 2025)

Shares outstanding

40,266,149

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

7/31

THC Therapeutics, Inc. leadership

• Brandon David Romanek — Founder, CEO, President

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with T